Dan Littman, MD, PhD

New York University
Howard Hughes Medical Institute


Dr. Dan Littman, a world renowned immunologist, heads a large research group at NYU that focuses on T cells, a critical cell of the adaptive immune system and its role in inflammatory diseases. Dr. Littman also has extensive biopharmaceutical experience, currently serving on the Board of Directors of Pfizer and having founded two biotech companies: Vedanta Biosciences, Inc. and Orca Pharmaceuticals, Ltd.. Dr. Littman has been an Investigator of the Howard Hughes Medical Institute since 1987 and is a member of the National Academy of Sciences and the Institute of Medicine.

Go Back